Domov › Rakovina endometria › New Mexico
Klinické štúdie Rakovina endometria v štáte New Mexico
13 štúdií pre Rakovina endometria hľadá účastníkov v zariadeniach v štáte New Mexico.
Mestá v štáte New Mexico
Oficiálny text štúdie (anglicky)
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- University of New Mexico Cancer Center, Albuquerque
Prebieha náborFáza 2
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT05564377Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
- University of New Mexico Cancer Center, Albuquerque
Prebieha náborFáza 1
Vek 18 a viac · Ženy · Aktualizované 2. 10. 2026 · NCT05950464Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- University of New Mexico Cancer Center, Albuquerque
Prebieha náborFáza 3
Vek 18 a viac · Ženy · Aktualizované 2. 10. 2026 · NCT07198074Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- University of New Mexico Cancer Center, Albuquerque
Prebieha náborFáza 2
Vek 18 a viac · Ženy · Aktualizované 28. 9. 2026 · NCT05112601DESTINY-PANTUMOUR04
- Research Site, Farmington
Prebieha náborObservačná štúdia
Vek 18 až 130 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07124000Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
- Research Site, Albuquerque
Prebieha náborFáza 2
Vek 18 až 130 · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT05489211A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- University of New Mexico Comprehensive Cancer Center ( Site 6046), Albuquerque
Prebieha náborFáza 3
Vek 18 a viac · Ženy · Aktualizované 17. 9. 2026 · NCT06952504A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
- Research Site, Albuquerque
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 11. 9. 2026 · NCT05123482Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Albuquerque
Prebieha náborFáza 3
Vek 18 a viac · Ženy · Aktualizované 29. 7. 2026 · NCT07044336Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
- 292, Albuquerque
Prebieha náborFáza 2
Vek 18 a viac · Ženy · Aktualizované 16. 7. 2026 · NCT06906341Uterine Preservation Via Lifestyle Transformation
- University of New Mexico, Albuquerque
Prebieha náborFáza 2
Vek 18 a viac · Ženy · Aktualizované 20. 1. 2026 · NCT05903131Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
- University of New Mexico, Albuquerque
Prebieha náborFáza 1
Vek 18 a viac · Ženy · Aktualizované 11. 12. 2025 · NCT06795009SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Albuquerque
Prebieha náborObservačná štúdia
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.